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Diabetes downregulates large-
conductance Ca2+-activated 
potassium β1 channel subunit
A major factor regulating the contractile state of arterioles is the 
activity of ion channels on the plasma membranes of vascular 
smooth muscle cells (VSMCs). Among these channels, the 
large-conductance calcium (Ca2+)-activated potassium (K+; 
BK) channel is known to play a crucial role, because its blockade 
with iberiotoxin causes VSMC membrane depolarization and 
vasoconstriction. BK channels are activated by local Ca2+ release 
events, termed Ca2+ sparks, resulting from opening of ryanodine 
receptor channels in the sarcoplasmic reticulum. Activation 
of BK channels results in outward K+ current, which causes 
membrane hyperpolarization. Reduction of the activation of 
voltage-dependent Ca2+ channels decreases Ca2+ infl ux and 
opposes VSMC contraction. BK channels are composed of 
α-subunits and accessory β-subunits. Th e α-subunit forms the 
K+-selective pore, whereas the β-subunits infl uence the kinetics, 
pharmacology, and Ca2+ sensitivity of BK currents. Four 
members of the BKβ subunit family have been identifi ed to date 
(β1–β4); the β1-subunit is expressed predominantly in VSMCs. 
Targeted deletion of the β1-subunit gene reduces the Ca2+ 
sensitivity of BK channels and the coupling of Ca2+ sparks to BK 
channel activity. Th e functional signifi cance of the β1-subunit 
of VSMC BK channels is underlined by the observation that 
knockout mice are hypertensive and display enhanced vascular 
reactivity to application of vasoconstrictors.
Diabetes causes many vascular abnormalities, including 
increased arterial pressure. McGahon et al. examined the 
eff ects of streptozotocin-induced diabetes on the properties 
of BK channels in VSMCs of the rat retinal microcirculation. 
Th ey found that in nondiabetic retinal arterioles, BK channel 
inhibitors induced vascular constriction, and that in retinal 
arterioles from diabetic animals, the BK current induced by 
caff eine was dramatically reduced despite the fact that caff eine-
evoked [Ca2+] release was unaff ected. Moreover, spontaneous 
BK currents were smaller in diabetic cells, but the amplitude 
of Ca2+ sparks was larger. Th e amplitudes of BK currents 
elicited by depolarizing voltage steps were similar in control 
and diabetic arterioles. In addition, mRNA expression of the 
pore-forming BKα subunit was unchanged by diabetes. In 
contrast, both transcript and protein levels for BKβ1 were 
appreciably lower in diabetic retinal arterioles (Figure). Because 
the BKβ1 subunit confers Ca2+ sensitivity to BK channel 
complexes, the Ca2+ sensitivity of single BK channels from 
diabetic retinal VSMCs was markedly reduced. Th us, changes 
in the molecular composition of BK channels may account for 
retinal hypoperfusion in early diabetes, a fi nding with wider 
implications for the pathogenesis of diabetic hypertension. 
(Circ Res 2007; 100: 703–711)
Juan Oliver
Poor CD4+CD23high T-regulatory-
cell function in patients with SLE
Studies in mice provide strong evidence for the existence of a 
unique CD4+CD25+ population of regulatory/suppressor T cells 
that prevent activation of autoreactive T cells that have escaped 
other mechanisms of tolerance. Removal of this population 
in rodents leads to the spontaneous development of various 
autoimmune diseases. Recent studies have revealed the presence 
of CD4+CD25+ T cells in human peripheral blood, where 
they constitute up to 5% of the CD4+ T cells. Generation of 
CD4+CD25+ T regulatory cells (Tregs) in the immune system 
is developmentally and genetically controlled; studies have 
demonstrated that the transcription factor FoxP3 is essential 
for their development. Hence, genetic defects that primarily 
aff ect the development or function of CD4+CD25+ Tregs could 
be a primary cause of autoimmune and other infl ammatory 
disorders in humans. Systemic lupus erythematosus (SLE), the 
prototypical systemic autoimmune disease, is characterized 
by a wide spectrum of clinical manifestations and abundant 
production of autoantibodies to nuclear antigens, cell surface 
molecules, and serum proteins. One possible explanation 
for the emergence of autoimmunity in diseases such as SLE 
could relate to defi cient function of Tregs; this would result in 
increased T-helper-cell activity or enhanced B-cell activity, both 
of which have been shown to be regulated by Tregs in normal 
subjects. Indeed, murine models that lack CD4+CD25+ Tregs 
develop a systemic autoimmune disease, characterized by 
gastritis, oophoritis, arthritis, and thyroiditis. Interestingly, some 
animal models lacking Tregs also develop glomerulonephritis 
and increased titers of anti-double-stranded DNA, which are 
hallmarks of SLE.
Initial studies in SLE suggested a decrease in circulating 
CD4+CD25+ T cells in patients with active disease. But the 
potential role of Tregs in SLE remains to be fully delineated. It 
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Confocal images of nondiabetic and diabetic retinal arterioles labeled with 
anti-BKβ1 antibody (green) and propidium iodide (red; nuclear label).
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is now possible to assess human Treg function in vitro and the 
presence and function of Tregs in human autoimmune diseases 
using fl ow cytometric analysis of cell surface phenotypes 
and determination of FoxP3 expression. Valencia et al. used 
these approaches to compare the frequency and function of 
CD4+CD25high Tregs in a group of SLE patients and in age-
matched healthy control subjects. CD4+CD25high Tregs from 
active but not from inactive SLE patients manifested defi cient in 
vitro suppressive activity. Importantly, this defect was associated 
with decreased FoxP3 mRNA and protein that was restored aft er 
in vitro stimulation. Hence, a reversible defect in Treg function 
may contribute to fl ares of disease activity in patients with SLE. 
(J Immunol 2007; 178: 2579–2588)
Detlef Schlöndorﬀ 
WNK4 regulates Na+ and K+ channel 
activity
Homeostasis of intravascular volume, Na+, Cl–, and K+ is 
interdependent and determined by the coordinated activities 
of structurally diverse mediators in the distal nephron and 
colon. Th e behavior of these fl ux pathways is regulated 
by the renin–angiotensin–aldosterone system; however, 
the mechanisms that allow independent modulation of 
individual elements have been obscure. For example, 
although aldosterone secretion increases in response to both 
intravascular volume depletion and hyperkalemia (increased 
plasma K+ levels), the mechanisms that permit maximal NaCl 
reabsorption have been poorly understood. One of the most 
exciting breakthroughs in this fi eld was the recent discovery 
that mutations in WNK4 cause pseudohypoaldosteronism 
type II (PHAII), a disease featuring hypertension with 
hyperkalemia, due to altered activity of Na-Cl cotransporters 
(thiazide-sensitive), of the renal outer medullary K+ channel 
(ROMK), and of paracellular Cl– fl ux mediators of the 
distal nephron.
Two exciting recent manuscripts add further complexity to 
the role of WNK4 in electrolyte transport. By coexpression 
studies in Xenopus oocytes, Ring et al. found that WNK4 
inhibited the epithelial Na+ channel (ENaC), the major mediator 
of aldosterone-sensitive Na+ reabsorption. Th is inhibition 
was independent of WNK4’s kinase activity. Importantly, 
PHAII-causing mutations eliminated WNK4’s inhibition of 
ENaC, thereby paralleling other eff ects of PHAII to increase 
sodium balance. Th e authors also studied the relevance of these 
fi ndings in vivo in mice harboring PHAII-mutant WNK4. Th e 
colonic epithelium of these mice showed markedly increased 
amiloride-sensitive Na+ fl ux as compared with wild-type 
littermates (Figure 1). Th ese interesting studies identify ENaC 
as a previously unrecognized downstream target of WNK4 and 
demonstrate a functional role for WNK4 in the regulation of 
colonic Na+ absorption.
In an accompanying article, Ring et al. more directly examined 
the question of how aldosterone, which is secreted both in 
intravascular volume depletion and in hyperkalemia, can 
maximize renal NaCl reabsorption in the former state while 
maximizing K+ secretion in the latter. Th ey found that WNK4 is 
phosphorylated by SGK1, a mediator of aldosterone signaling. 
Whereas wild-type WNK4 inhibited the activity of both ENaC 
and ROMK, a WNK4 mutation that mimics phosphorylation 
at the SGK1 site (WNK4S1169D) alleviated inhibition of both 
channels. Th e net result of these eff ects in the kidney would be 
increased K+ secretion, because of both increased electrogenic 
Na+ reabsorption and increased apical membrane K+ 
permeability. Th us, modifi cation at the PHAII and SGK1 sites 
in WNK4 imparted opposite eff ects on K+ secretion, decreasing 
or increasing ROMK activity and net K+ secretion, respectively 
(Figure 2). Th is promotes the desired physiologic response 
to hyperkalemia, and the fact that it is induced downstream 
of aldosterone signaling implicates WNK4 in the physiologic 
response to aldosterone with hyperkalemia. Together, the 
diff erent states of WNK4 allow the kidney to provide distinct 
and appropriate integrated responses to intravascular volume 
depletion and hyperkalemia. (Proc Natl Acad Sci USA 2007; 104: 
4020–4024. Proc Natl Acad Sci USA 2007; 104: 4025–4029)
Qais Al-Awqati
Figure 1 | Immunolocalization of WNK4 in the mouse colon.
Figure 2 | WNK4 orchestrates differential responses to hypovolemia 
and hyperkalemia. IV, intravascular; aldo, aldosterone; AII, angiotensin II.
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